BHC:NYSE
Bausch Health Companies Inc
$8.35
arrow_upward
+1.15%(+0.095) 1D
$8.33
arrow_downward
-0.24% (-0.020)bedtimeAfter hours
Closed: Nov 13, 4:00:03 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BHC...
Open
$8.25
High
$8.40
Low
$8.18
Mkt. cap
3.13B
Avg. vol.
3.86M
Volume
2.34M
52-wk high
$9.04
52-wk low
$4.33
EPS
-$2.29
Beta
0.30
Shares outstanding
374.27M
No. of employees
20K
Open
$8.25
High
$8.40
Low
$8.18
Mkt. cap
3.13B
Avg. vol.
3.86M
Volume
2.34M
52-wk high
$9.04
52-wk low
$4.33
EPS
-$2.29
Beta
0.30
Shares outstanding
374.27M
No. of employees
20K
News stories
From web sources and news partners
Zacks
·
1 day ago
Here's Why Bausch Health (BHC) is a Strong Momentum Stock
Profile
Bausch Health Companies Inc. is a pharmaceutical company headquartered in Laval, Quebec, Canada, with office in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in gastroenterology, hepatology, neuroscience, dermatology, dentistry, medical aesthetics, and international pharmaceuticals.
Bausch Health manufactures and markets branded pharmaceuticals, generic pharmaceuticals, and over-the-counter products directly or indirectly in more than 90 countries and regions, including the United States, Canada, Europe, the Middle East, Africa, Asia Pacific and Latin America. Wikipedia
About Bausch Health Companies Inc
CEOThomas J. Appio
Employees20.3K
Founded1960
HeadquartersLaval, Quebec, Canada
SectorHealth Care
IndustryPharmaceutical industry
Websitebauschhealth.com